Expedia Group, Inc. has been experiencing a turbulent journey on the NASDAQ, resulting in constant shifts in its shares' dynamics. The stock encountered a decline following the release of its Q1 report, mostly attributed to subdued U.S. travel demand and its consequential impact on bookings. This has led to various firms, including Banks of America and Susquehanna, issuing forecasts for
EXPE's future performance, with the former being optimistic and the latter pessimistic.
Despite the turmoil,
EXPE continues to appear among billionaire Mason Morfit's favorable stock selections with high upside potential. Furthermore, there are also projections of a bullish reversal pattern that could potentially take the
EXP stock towards a $200 price target. However, several equity management firms like Jacobs Levy and Patient Capital Management have reduced their Expedia Group holdings, indicating a cautious attitude.
As per the latest updates, despite a few downgrades, Barclays recently boosted Expedia Group's price target to $190.00. Concurrently, the anticipation around Expedia's upcoming earnings also seems to influence the stock's course. Meanwhile, travel industry trends have been contributing significantly to the
EXPE market performance with fluctuations based on sentiments surrounding the industry's resilience.
Expedia Stocks EXPE News Analytics from Mon, 14 Oct 2024 07:00:00 GMT to Sat, 17 May 2025 10:31:41 GMT -
Rating -4
- Innovation 4
- Information 8
- Rumor -2
